drugset / Trial / NCT00444704

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females

NCT00444704 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The primary purpose of this study is to assess the safety and tolerability of ascending single oral doses of PRA-027 in healthy Japanese females. The secondary purpose is to provide the initial pharmacokinetic and pharmacodynamic profiles of PRA-027 in healthy Japanese female subjects.

Timeline

Start
2007-03
Primary completion
—
Completion
2007-12

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-05019702 Unknown — Oral

Indications